Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.
Newcastle’s disease is one of the most important infectious diseases of poultry, caused by Newcastle Disease Virus. This virus is distributed worldwide and can lead to serious economic losses in the poultry industry due to recurring epidemics in vaccinated and unvaccinated herds. The protection against the NDV in the chickens has been associated with the development of the humoral response. Although the hemagglutination inhibition test and ELISA does not corroborate the presence of neutralizing antibodies; They are used to measure the protection and immune response against NDV.
In this study, we created a system to recover a recombinant NDV from a cloned cDNA capable of accepting exogenous genes in the desired positions. An improved green fluorescent protein (EGFP) was designed in the first position of the NDV genome and generated a recombinant. This NDV-EGFP journalist virus was used to develop a FGFP-based neutralization test, in which NABS titles were expressed as reciprocal of the highest dilution that expressed EGFP.
EGFP-NT gave conclusive results in 24 hours without using additional coloring procedure. A total of 57 serum samples were analyzed by conventional neutralization (NT) and EGFP-NT. In addition, HI and a Commercial Elisa Kit have been evaluated with the same set of samples. Although HI and ELISA showed a substantial correlation with standard NT, EGFP-NT showed a higher correlation, indicating that EGFP-NT is a method More precise to quantify NABs.
Doping of the green fluorescent protein in superfluid helium droplets: size and speed of doped droplets.
We note the doping of the green fluorescent protein from an electrospray ionization source (ESI) in superfluid helium droplets. Analyzes of temporal profiles of doped droplets, we identify two distinct groups of droplets. The faster group has a smaller average size, of the order of 106 atoms / droplets of helium, and the slower group is much larger, by at least one order of magnitude. The relative populations of these two groups depend on the temperature of the source droplet: from 11 to 5 K, the signal intensity of the group of lower droplets gradually increases, closely from the detection limit to that of the faster group.
We post that the smaller droplets are formed via the condensation of gaseous helium during the expansion of the pulsed valve, while the larger droplets are developing the fragmentation of the ejected liquid helium. Our results on the size and speed of the condensing peak at temperatures above the source (> 7 k) agrees with the previous reports, but those at lower temperatures (<7 K) appear to be extinguished. We assign this divergence to the masking effect of extremely large droplets of the fragmentary peak in previous measurements of droplet sizes. In the temperature range of our survey, although the expansion requirement changes from supercritical subcriture, there is no steep modification of the distribution of the speed or distribution of the condensation peak, and L The most salient effect is in the growing intensity of fragmentation. peak.
The effectiveness of absolute doping, as expressed by the ratio of droplets doped ions on the total number of ions from the ESI source, is of the order of 10 to 4, while only hundreds of ions. doped have been detected. Other improvements in the ESI source are essential to prolong the technology of future experiences. On the other hand, the separation of the two groups of speed droplets is beneficial for selecting the size of only smaller droplets for future electronic diffraction experiments.
An unisleascent correlation between the dynamics of the chromophore chromophore pocket of green fluorescent proteins and hydrogen: a choreography of the Molecular Dynamics AB initio
The green fluorescent protein (GFP) is a chemical system largely studied for both its large amount of applications and the complexity of the proton transfer of the excited state responsible for the variation of the protection state of the chromophore. A detailed investigation into the structure of the chromophore environment and the influence of the chromophore (neutral or anionic) form is of crucial importance to understand how these factors could potentially influence protein function. In this study, we carry out a detailed computer inquiry based on the analysis of the simulations of molecular dynamics ab-initio, in order to unravel the main structural quantities determining the fine balance in the chromic environment.
We have found that specific hydrogen-related interactions directly involving the chromophore (or not), are correlated to quantities, such as the volume of the cavity in which the chromophore is integrated and importantly important by the State of the Cartenariat of the Chromophore. The cross-sectional correlation analysis carried out on some of these hydrogen links and the volume of the cavity, demonstrates a direct correlation between them and we have also identified those specifically involved in this correlation. We also found that specific interactions between residues by far in space are correlated, demonstrating the complexity of the chromophore environment and that many structural amounts must be taken into account to describe and understand the main factors to settle.
pCDH- CMV- MCS- EF1- puro |
|||
PVT11075 | Lifescience Market | 2 ug | EUR 444 |
mCherry (EF1a, Puro), Concentrated Lentivirus |
|||
LVP1420-PBS | GenTarget | 1x10^8 IFU/ml x 200ul | EUR 455 |
Description: mCherry expression lentivirus under EF1a promoter, carrying Puromycin selection |
pCDH- CMV- MCS- EF1- turboRFP- T2A- Puro |
|||
PVT11077 | Lifescience Market | 2 ug | EUR 444 |
pGreen- Puro- pSIH1- H1- copGFP- T2A- Puro |
|||
PVT11116 | Lifescience Market | 2 ug | EUR 444 |
pAAV- CMV- mCherry- U6- sgRNA |
|||
PVT11046 | Lifescience Market | 2 ug | EUR 361.2 |
pCDH-CMV-SLC39A6(Macaca)-EF1-CopGFP-T2A-Puro |
|||
PVT39683 | Nova Lifetech | 2ug | EUR 280 |
pLKO.1-mCherry-Puro |
|||
PVT20316 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MCS-EF1-GFP+Puro |
|||
PVTY00180 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-VIL1-EF1-CopGFP-T2A-Puro |
|||
PVT22107 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-CDK9-EF1-CopGFP-T2A-Puro |
|||
PVT23495 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-Cdk9-EF1-CopGFP-T2A-Puro |
|||
PVT23496 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-SGK1-EF1-CopGFP-T2A-Puro |
|||
PVT38586 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-EPOR-EF1-CopGFP-T2A-Puro |
|||
PVT26518 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-ITGB1-EF1-CopGFP-T2A-Puro |
|||
PVT20736 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-Pdcd1-EF1-CopGFP-T2A-Puro |
|||
PVT23040 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MYO19-EF1-CopGFP-T2A-Puro |
|||
PVT23509 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-SYVN1-EF1-CopGFP-T2A-Puro |
|||
PVT25902 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-SIRT1-EF1-CopGFP-T2A-Puro |
|||
PVT29553 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-Akaluc-EF1-CopGFP-T2A-Puro |
|||
PVT14490 | Lifescience Market | 2 ug | EUR 718.8 |
pCDH-CMV-ZNF503-EF1-CopGFP-T2A-Puro |
|||
PVT32532 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MIR495-EF1-CopGFP-T2A-Puro |
|||
PVT33146 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-TRIM37-EF1-CopGFP-T2A-Puro |
|||
PVT23076 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-YTHDC1-EF1-CopGFP-T2A-Puro |
|||
PVT31678 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MIR378A-EF1-CopGFP-T2A-Puro |
|||
PVT31990 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MIR4262-EF1-CopGFP-T2A-Puro |
|||
PVT31488 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-KIAA1429-EF1-CopGFP-T2A-Puro |
|||
PVT30145 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MAPKAPK5-EF1-CopGFP-T2A-Puro |
|||
PVT37893 | Nova Lifetech | 2ug | EUR 280 |
pHG52d34.5-CMV-PD-1(b)-mCherry |
|||
PVT12169 | Lifescience Market | 2 ug | EUR 843.6 |
pCDH-CMV-LINC00622-EF1-CopGFP-T2A-Puro |
|||
PVT23118 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-LINC01057-EF1-CopGFP-T2A-Puro |
|||
PVT23300 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-LINC01356-EF1-CopGFP-T2A-Puro |
|||
PVT23307 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-LINC01348-EF1-CopGFP-T2A-Puro |
|||
PVT23313 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-LINC00412-EF1-CopGFP-T2A-Puro |
|||
PVT23455 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-LINC00494-EF1-CopGFP-T2A-Puro |
|||
PVT24213 | Nova Lifetech | 2ug | EUR 280 |
pCDNA3.1- mCherry |
|||
PVT10770 | Lifescience Market | 2 ug | EUR 319.2 |
pCDH-CMV-MCS-EF1-copGFP |
|||
PVTY00932 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-PBX1-EF1-copGFP |
|||
PVT31992 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-GPAT3-EF1-copGFP |
|||
PVT20300 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-FCGR2B-EF1-copGFP |
|||
PVT31502 | Nova Lifetech | 2ug | EUR 280 |
pBABE-puro mCherry-EGFP-LC3B |
|||
PVT14018 | Lifescience Market | 2 ug | EUR 1093.2 |
pCDH-CMV-3XFLAG-MCS-EF1-CopGFP-T2A-Puro |
|||
PVT30391 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-ccl3-m-EF1-CopGFP-T2A-Puro |
|||
PVT19054 | Lifescience Market | 2 ug | EUR 360 |
pCDH-CMV-RAC1-1-EF1-CopGFP-T2A-Puro |
|||
PVT30007 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-Ccl4-m-EF1-CopGFP-T2A-Puro |
|||
PVT19908 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MCS-Myc-EF1-CopGFP-T2A-Puro |
|||
PVT30308 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-efemp1-m-EF1-CopGFP-T2A-Puro |
|||
PVT17438 | Lifescience Market | 2 ug | EUR 360 |
pCDH-CMV-TXNL1-HA-EF1-CopGFP-T2A-Puro |
|||
PVT17693 | Lifescience Market | 2 ug | EUR 309.6 |
pCDH-CMV-SCD-FLAG-EF1-CopGFP-T2A-Puro |
|||
PVT38393 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-FLAG-MCS-EF1-CopGFP-T2A-Puro |
|||
PVT30680 | Nova Lifetech | 2ug | EUR 280 |
pLV3-CMV-LMP-1(HBV)-CopGFP-Puro Plasmid |
|||
PVT50284 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-MCS-EF1-copGFP-T2A-Puro plasmid |
|||
PVT17271 | Lifescience Market | 2 ug | EUR 568.8 |
pCDH-CMV-CCDC68-HA-EF1-CopGFP-T2A-Puro |
|||
PVT17760 | Lifescience Market | 2 ug | EUR 309.6 |
pCDH-CMV-FLAG-IRF4-EF1-CopGFP-T2A-puro |
|||
PVT30000 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-PTX3-EF1-CopGFP-T2A-Puro Plasmid |
|||
PVT17116 | Lifescience Market | 2 ug | EUR 390 |
pCDH-CMV-SLC15A5-HA-EF1-CopGFP-T2A-Puro |
|||
PVT33187 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-SAR1A-FLAG-EF1-CopGFP-T2A-Puro |
|||
PVT30117 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-TTYH1-FLAG-EF1-CopGFP-T2A-Puro |
|||
PVT27428 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-YAP1-S127A-EF1-CopGFP-T2A-Puro |
|||
PVT27718 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-YAP1-3XFLAG-EF1-CopGFP-T2A-Puro |
|||
PVT33425 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-SREBF1-FLAG-EF1-CopGFP-T2A-Puro |
|||
PVT29740 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-FKBP1A-FLAG-EF1-CopGFP-T2A-Puro |
|||
PVT30112 | Nova Lifetech | 2ug | EUR 280 |
pCDH- EF1- MCS- T2A- Puro Plasmid |
|||
PVT2335 | Lifescience Market | 2 ug | EUR 390 |
pCDH-CMV-exosome booster-EF1-copGFP-Puro vector |
|||
PVT12109 | Lifescience Market | 2 ug | EUR 1149.6 |
mCherry |
|||
GT22108 | Neuromics | each | EUR 272.7 |
mCherry |
|||
MBS556090-01mL | MyBiosource | 0.1mL | EUR 435 |
mCherry |
|||
MBS556090-5x01mL | MyBiosource | 5x0.1mL | EUR 1815 |
mCherry |
|||
MO22192 | Neuromics | 100 ul | EUR 292.5 |
pCDH-CMV-MCS-EF1-copGFP+Puro cDNA Clon/Exp Vector [pre-packaged] |
|||
CD513VB-1 | SBI | >1 x 10^6 IFUs | EUR 720 |
pAAV-CMV-hChR2(H134R)-mCherry Plasmid |
|||
PVT45728 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-GSTA1-EF1-copGFP Plasmid |
|||
PVT16093 | Lifescience Market | 2 ug | EUR 390 |
pCDH-EF1-copGFP-T2A-Puro Plasmid |
|||
PVT45263 | Nova Lifetech | 2ug | EUR 280 |
pT2- mCherry |
|||
PVT10881 | Lifescience Market | 2 ug | EUR 361.2 |
AIO- mCherry |
|||
PVT10959 | Nova Lifetech | 2ug | EUR 215 |
pLV- mCherry |
|||
PVT11094 | Lifescience Market | 2 ug | EUR 361.2 |
pcDNA3 AIF 1-90 mCherry FRB |
|||
PVT28991 | Nova Lifetech | 2ug | EUR 280 |
pDawn- mCherry |
|||
PVT10619 | Lifescience Market | 2 ug | EUR 361.2 |
mCherry - Mouse |
|||
MO22140 | Neuromics | 100 ul | EUR 292.5 |
pCDH-CMV-FLAG-C-Maf-EF1-CopGFP-T2A-Puro |
|||
PVT33144 | Nova Lifetech | 2ug | EUR 280 |
pUC35s- mCherry |
|||
PVT11192 | Lifescience Market | 2 ug | EUR 319.2 |
pNanog- mCherry |
|||
PVT10426 | Lifescience Market | 2 ug | EUR 319.2 |
pBV220- mCherry |
|||
PVT10620 | Lifescience Market | 2 ug | EUR 361.2 |
pRSETB- mCherry |
|||
PVT10624 | Lifescience Market | 2 ug | EUR 361.2 |
pET28a- mCherry |
|||
PVT0075 | Lifescience Market | 2 ug | EUR 307.2 |
rAAV-CMV-DIO-hM3D(Gq)-mCherry-WPREs |
|||
PT-0989 | BrainVTA | 1 vial | Ask for price |
Description: Adeno-associated virus vector. |
pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro-IGFBP7-3xFLAG |
|||
PVT28058 | Nova Lifetech | 2ug | EUR 280 |
mCherry, Purified Chicken IgY |
|||
MBS555646-01mL | MyBiosource | 0.1mL | EUR 435 |
mCherry, Purified Chicken IgY |
|||
MBS555646-5x01mL | MyBiosource | 5x0.1mL | EUR 1815 |
mCherry antibody |
|||
70R-12458 | Fitzgerald | 100 ug | EUR 490 |
Description: Rabbit polyclonal mCherry antibody |
mCherry Antibody |
|||
5993-100 | Biovision | each | EUR 483.6 |
mCherry Antibody |
|||
5993-30T | Biovision | each | EUR 175.2 |
mCherry Antibody |
|||
abx159607-100g | Abbexa | 100 µg | Ask for price |
mCherry Antibody |
|||
20-abx159607 | Abbexa |
|
|
mCherry Antibody |
|||
abx159607-10g | Abbexa | 10 µg | EUR 187.5 |
mCherry Antibody |
|||
abx159607-50g | Abbexa | 50 µg | EUR 250 |
mCherry Antibody |
|||
abx347160-100g | Abbexa | 100 µg | Ask for price |
mCherry Antibody |
|||
abx347160-20g | Abbexa | 20 µg | EUR 350 |
mCherry Antibody |
|||
abx347160-50g | Abbexa | 50 µg | Ask for price |
mCherry Antibody |
|||
abx332840-100g | Abbexa | 100 µg | Ask for price |
mCherry Antibody |
|||
abx332840-100ul | Abbexa | 100 ul | EUR 510 |
mCherry Antibody |
|||
abx332840-20g | Abbexa | 20 µg | EUR 362.5 |
mCherry Antibody |
|||
abx332840-50g | Abbexa | 50 µg | Ask for price |
mCherry Antibody |
|||
abx375280-96tests | Abbexa | 96 tests | EUR 337.5 |
mCherry Antibody |
|||
MBS415041-01mL | MyBiosource | 0.1mL | EUR 410 |
mCherry Antibody |
|||
MBS415041-5x01mL | MyBiosource | 5x0.1mL | EUR 1585 |
mCherry Antibody |
|||
MBS415115-01mL | MyBiosource | 0.1mL | EUR 410 |
mCherry Antibody |
|||
MBS415115-5x01mL | MyBiosource | 5x0.1mL | EUR 1585 |
mCherry antibody |
|||
MBS835238-01mg | MyBiosource | 0.1mg | EUR 640 |
mCherry antibody |
|||
MBS835238-5x01mg | MyBiosource | 5x0.1mg | EUR 2845 |
mCherry-Rabbit |
|||
RA22117 | Neuromics | 100 ul | EUR 292.5 |
mCherry-Chicken |
|||
CH22115 | Neuromics | 100 ul | EUR 292.5 |
PA- mCherry- C1 |
|||
PVT10759 | Lifescience Market | 2 ug | EUR 361.2 |
PA- mCherry- N1 |
|||
PVT10760 | Lifescience Market | 2 ug | EUR 361.2 |
mCherry (monoclonal) |
|||
AS16-3967 | Agrisera AB | 100 µg | EUR 331 |
pCDH- CMV- MCS- EF1- Hygro |
|||
PVT11076 | Lifescience Market | 2 ug | EUR 444 |
pCDH-CMV-MCS-EF1-Puro |
|||
PVTY00775 | Nova Lifetech | 2ug | EUR 280 |
pLVX- mCherry- N1 |
|||
PVT11067 | Lifescience Market | 2 ug | EUR 361.2 |
pLVX- mCherry- C1 |
|||
PVT11068 | Lifescience Market | 2 ug | EUR 444 |
pCDH-CMV-LDLR-EF1-Puro |
|||
PVT39521 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-GAS6-EF1-Puro |
|||
PVT28499 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-FUT10-EF1-Puro |
|||
PVT22013 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-FUT11-EF1-Puro |
|||
PVT22014 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-TOR1B-EF1-puro |
|||
PVT38408 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-CLDN5-EF1-puro |
|||
PVT28403 | Nova Lifetech | 2ug | EUR 280 |
pCDH-CMV-USP31-EF1-Puro |
|||
PVT20366 | Nova Lifetech | 2ug | EUR 280 |
The active site of the protein. Of an overall assessment of the results obtained in this work, it is shown that the residues that the spectators are perceived as spectators play both an important role in the influence on the chromophore environment (volume of the cavity) and its dynamic (crossed correlations between them. Remote residues)